Medical Science News

RSS

Muscle benefits of lifting weights while taking tirzepatide

Resistance training alongside tirzepatide helped adults with obesity retain more lean tissue and gain strength without reducing weight-loss benefits.

12 Nov 2026

Researchers uncover how surrounding cells fuel triple-negative breast cancer growth

Triple-negative breast cancer, which accounts for approximately 10–15% of all breast cancer cases, is considered particularly difficult to treat because it grows rapidly and carries a high risk of recurrence.

12 Nov 2026

Researchers identify promising new immune target for treating endometriosis

Affecting 200 million women of reproductive age, endometriosis is a chronic inflammatory disease that causes pain, infertility, and increased ovarian cancer risk.

12 Nov 2026

A pain in the neck? New Adelaide University trial offers hope

Whether you hunch over a computer or spend hours scrolling on your phone, everyday habits can be a real pain in the neck. But when that pain persists, it can take a serious toll on everyday life, affecting everything from work and sleep to physical activity and wellbeing.

12 Nov 2026

Phone reminders stop nighttime snacking, but not for long

An after dinner or bedtime snack can be hard to resist, but could a gentle nudge from a smartphone app help people with type two diabetes to quit the common habit?

12 Nov 2026

Orexo and SVF Vaccines collaborate to explore AmorphOX® formulation of LNP-mRNA vaccines

Orexo AB and SVF Vaccines AB today announced a research collaboration to investigate whether Orexo’s proprietary powder-based drug delivery technology, AmorphOX®, can be used to develop stable powder-based formulations of lipid nanoparticle (LNP)-encapsulated messenger RNA (mRNA) vaccines.

12 Nov 2026

Richmond Pharmacology highlights encouraging first-in-human results for Regeneron's investigational RNAi therapy in MASLD

Richmond Pharmacology, a specialist early-phase clinical research organization, has announced encouraging results from a first-in-human clinical trial evaluating CIDEBsiRNA, an investigational RNA interference (RNAi) therapy developed by Regeneron Pharmaceuticals, Inc.

12 Nov 2026

Ephrin-B1 phosphorylation disrupts nephrin complexes in nephrotic syndrome pathogenesis

A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University identified a novel Ca2+-independent pathogenic mechanism of nephrotic syndrome.

12 Nov 2026

New method reveals how individual glioblastoma cells spread through the brain

By combining live imaging of brain tissue with artificial intelligence, researchers at Uppsala University have developed a method that reveals how individual glioblastoma cells spread through the brain, how they can switch between different ways of moving, and how they are affected by cancer treatments. An

12 Nov 2026

Type 2 diabetes accelerates jawbone loss and causes tooth loss

Type 2 diabetes (T2D) is a chronic metabolic disorder whose global burden continues to rise. Beyond its systemic effects, T2D compromises skeletal health and markedly worsens loss of alveolar bone—the bone that anchors teeth—leading to tooth loosening, increased mobility, and eventual tooth loss.

11 Nov 2026

Environmental experiences trigger widespread changes in brain cell connections

Experiences and changes in environment cause widespread alterations in connections between brain cells, influencing brain activity, research suggests.

11 Nov 2026

BNP hormone may actively promote blood clot formation, study finds

A hormone found in the blood and long viewed as a biological "check engine light" may do more than signal cardiovascular distress, according to researchers with the Texas A&M University Irma Lerma Rangel College of Pharmacy at Texas A&M Health.

11 Nov 2026

Declining thermogenic fat activity may explain age-related cold sensitivity

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered the biological reason for why we become more sensitive to cold as we get older.

11 Nov 2026

New molecular approach shows promise against treatment-resistant prostate cancer

Many modern cancer drugs typically target a specific protein or signaling pathway to treat tumors.

11 Nov 2026

$7.2 million NIH funding supports research into long-lived plasma cells

Central to many immune responses are antibodies, which identify foreign substances and help remove them from the body. The immune cells that produce them are called plasma cells, and they can mature into long-lived plasma cells that persist and provide protection for years or even decades.

11 Nov 2026

Vaping frequency linked to declining lung function in young adults

Long term vaping in young people may induce persistent changes in lung function, suggest preliminary findings published online in the journal Tobacco Control.

11 Nov 2026

Positive psychology may help young adults build lifelong resilience

For a long time, scientists thought that brain development was an exclusive feature of childhood, but now we understand that the brains of older teenagers and young adults undergo one of the most remarkable reorganizations in human lifetime.

11 Nov 2026

Chronic stress promotes oral cancer through a brain–immune pathway

Chronic psychological stress is increasingly recognized as a risk factor for cancer, but how the brain communicates with the immune system to promote tumors has remained unclear.

11 Nov 2026

Gut microbial metabolites may reshape fat tissue through Wnt pathways

Fat tissue grows in two ways: existing fat cells swell, or progenitor cells spawn new fat cells. When new-cell formation falls behind long-term energy surplus, lipids pile up inside aging fat cells-bringing inflammation, insulin resistance, and fat deposits in the liver and muscle.

11 Nov 2026

‘Forever chemicals’ linked to slightly lower muscle mass in middle-aged women

A study of 551 middle-aged women found that higher blood concentrations of certain PFAS chemicals were associated with slightly lower muscle mass, particularly when researchers examined multiple chemicals together. However, these associations did not correspond to poorer muscle function, and the largely cross-sectional findings could not establish whether PFAS exposure contributes to muscle loss.

11 Nov 2026